Astellas is aiding Vir Biotechnology’s oncology pivot with a $1.7 billion global collaboration focused on a potential best-in-class T-cell engager…

In the ever-evolving landscape of neonatal care, the role of neonatologists stands paramount. A recently published study in the Journal…

In a groundbreaking study set to redefine our understanding of Parkinson’s disease (PD) and its cognitive dimensions, researchers have uncovered…

In a groundbreaking development that promises to revolutionize sustainable chemical manufacturing, researchers at the University of Edinburgh have unveiled an…

The vast tropical peatlands and swamps are vital components of the Earth’s global carbon cycle, playing a critical role in…

In a comprehensive, nationwide study led by researchers at the Harvard T.H. Chan School of Public Health, a previously underexplored…

After teasing a new regulatory process for personalized genetic medicines at the end of last year, the FDA today unveiled…

In a groundbreaking study published in Cell Death Discovery, researchers have unveiled a novel cellular mechanism that could revolutionize our…

Rome-based Angelini Pharma has inked a multi-year deal with Massachusetts biotech Quiver Bioscience to advance novel therapies for genetic epilepsies,…

A phase 3 study of Gossamer Bio’s seralutinib in pulmonary arterial hypertension (PAH) has missed its primary endpoint, triggering a 77%…